Cargando…

A DNA vaccine targeting TcdA and TcdB induces protective immunity against Clostridium difficile

BACKGROUND: Clostridium difficile-associated disease (CDAD) constitutes a great majority of hospital diarrhea cases in industrialized countries and is induced by two types of large toxin molecules: toxin A (TcdA) and toxin B (TcdB). Development of immunotherapeutic approaches, either active or passi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Bao-Zhong, Cai, Jianpiao, Yu, Bin, Hua, Yanhong, Lau, Candy Choiyi, Kao, Richard Yi-Tsun Tsun, Sze, Kong-Hung, Yuen, Kwok-Yung, Huang, Jian-Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075199/ https://www.ncbi.nlm.nih.gov/pubmed/27770789 http://dx.doi.org/10.1186/s12879-016-1924-1

Ejemplares similares

Lectin Activity of the TcdA and TcdB Toxins of Clostridium difficile
por: Hartley-Tassell, Lauren E., et al.
Publicado: (2019)

CdtR Regulates TcdA and TcdB Production in Clostridium difficile
por: Lyon, Shelley A., et al.
Publicado: (2016)

Inhibition of Clostridium difficile TcdA and TcdB toxins with transition state analogues
por: Paparella, Ashleigh S., et al.
Publicado: (2021)

Inhibition of Clostridioides difficile Toxins TcdA and TcdB by Ambroxol
por: Heber, Sebastian, et al.
Publicado: (2022)

Association of tcdA+/tcdB+ Clostridium difficile Genotype with Emergence of Multidrug-Resistant Strains Conferring Metronidazole Resistant Phenotype
por: Shayganmehr, Farahnaz-Sadat, et al.
Publicado: (2015)

Human α-Defensin-5 Efficiently Neutralizes Clostridioides difficile Toxins TcdA, TcdB, and CDT
por: Korbmacher, Michael, et al.
Publicado: (2020)

The Compound U18666A Inhibits the Intoxication of Cells by Clostridioides difficile Toxins TcdA and TcdB
por: Papatheodorou, Panagiotis, et al.
Publicado: (2021)

Human α-Defensin-6 Neutralizes Clostridioides difficile Toxins TcdA and TcdB by Direct Binding
por: Barthold, Lara, et al.
Publicado: (2022)

Neutralising Effects of Different Antibodies on Clostridioides difficile Toxins TcdA and TcdB in a Translational Approach
por: Csukovich, Georg, et al.
Publicado: (2023)

Exploring the inhibitory potential of the antiarrhythmic drug amiodarone against Clostridioides difficile toxins TcdA and TcdB
por: Schumacher, Judith, et al.
Publicado: (2023)

Development and characterization of phage display-derived anti-toxin antibodies neutralizing TcdA and TcdB of Clostridioides difficile
por: Raeisi, Hamideh, et al.
Publicado: (2023)

Study of the frequency of Clostridium difficile tcdA, tcdB, cdtA and cdtB genes in feces of Calves in south west of Iran
por: Doosti, Abbas, et al.
Publicado: (2014)

Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections
por: Carter, Glen P., et al.
Publicado: (2015)

Ribotype Classification of Clostridioides difficile Isolates Is Not Predictive of the Amino Acid Sequence Diversity of the Toxin Virulence Factors TcdA and TcdB
por: Li, Zhenghui, et al.
Publicado: (2020)

Overexpression of the Endosomal Anion/Proton Exchanger ClC-5 Increases Cell Susceptibility toward Clostridium difficile Toxins TcdA and TcdB
por: Ruhe, Frederike, et al.
Publicado: (2017)

Nanobodies against C. difficile TcdA and TcdB reveal unexpected neutralizing epitopes and provide a toolkit for toxin quantitation in vivo
por: Kordus, Shannon L., et al.
Publicado: (2023)

A Colonic Organoid Model Challenged with the Large Toxins of Clostridioides difficile TcdA and TcdB Exhibit Deregulated Tight Junction Proteins
por: Schneemann, Martina, et al.
Publicado: (2023)

Variations in TcdB Activity and the Hypervirulence of Emerging Strains of Clostridium difficile
por: Lanis, Jordi M., et al.
Publicado: (2010)

Clinical and microbiologic characteristics of tcdA-negative variant clostridium difficile infections
por: Kim, Jieun, et al.
Publicado: (2012)

Amino Acid Differences in the 1753-to-1851 Region of TcdB Influence Variations in TcdB1 and TcdB2 Cell Entry
por: Hunt, Jonathan J., et al.
Publicado: (2017)

Intrinsic Toxin-Derived Peptides Destabilize and Inactivate Clostridium difficile TcdB
por: Larabee, Jason L., et al.
Publicado: (2017)

Novel Clostridium difficile Anti-Toxin (TcdA and TcdB) Humanized Monoclonal Antibodies Demonstrate In Vitro Neutralization across a Broad Spectrum of Clinical Strains and In Vivo Potency in a Hamster Spore Challenge Model
por: Qiu, Hongyu, et al.
Publicado: (2016)

The Role of TcdB and TccC Subunits in Secretion of the Photorhabdus Tcd Toxin Complex
por: Yang, Guowei, et al.
Publicado: (2013)

Indeterminate tcdB using a Clostridium difficile PCR assay: a retrospective cohort study
por: Leis, Jerome A, et al.
Publicado: (2013)

Designed Ankyrin Repeat Protein (DARPin) Neutralizers of TcdB from Clostridium difficile Ribotype 027
por: Peng, Zeyu, et al.
Publicado: (2019)

Putative Conjugative Plasmids with tcdB and cdtAB Genes in Clostridioides difficile
por: Ramírez-Vargas, Gabriel, et al.
Publicado: (2020)

TcdB of Clostridioides difficile Mediates RAS-Dependent Necrosis in Epithelial Cells
por: Stieglitz, Florian, et al.
Publicado: (2022)

Immunization with Recombinant TcdB-Encapsulated Nanocomplex Induces Protection against Clostridium difficile Challenge in a Mouse Model
por: Liu, Yi-Wen, et al.
Publicado: (2017)

Clostridium difficile 027/BI/NAP1 Encodes a Hypertoxic and Antigenically Variable Form of TcdB
por: Lanis, Jordi M., et al.
Publicado: (2013)

Esculin hydrolysis negative and TcdA‐only producing strains of Clostridium (Clostridioides) difficile from the environment in Western Australia
por: Shivaperumal, Nirajmohan, et al.
Publicado: (2022)

Development of Neutralizing and Non-neutralizing Antibodies Targeting Known and Novel Epitopes of TcdB of Clostridioides difficile
por: Fühner, Viola, et al.
Publicado: (2018)

Novel Biomarkers, Including tcdB PCR Cycle Threshold, for Predicting Recurrent Clostridioides difficile Infection
por: Madden, Gregory R., et al.
Publicado: (2023)

Isofagomine inhibits multiple TcdB variants and protects mice from Clostridioides difficile induced mortality
por: Paparella, Ashleigh S., et al.
Publicado: (2023)

Analysis of TcdB Proteins within the Hypervirulent Clade 2 Reveals an Impact of RhoA Glucosylation on Clostridium difficile Proinflammatory Activities
por: Quesada-Gómez, Carlos, et al.
Publicado: (2016)

Plakoglobin and High-Mobility Group Box 1 Mediate Intestinal Epithelial Cell Apoptosis Induced by Clostridioides difficile TcdB
por: Li, Yingxue, et al.
Publicado: (2022)

Structural basis for CSPG4 as a receptor for TcdB and a therapeutic target in Clostridioides difficile infection
por: Chen, Peng, et al.
Publicado: (2021)

The Antibiotic Bacitracin Protects Human Intestinal Epithelial Cells and Stem Cell-Derived Intestinal Organoids from Clostridium difficile Toxin TcdB
por: Zhu, Ziyu, et al.
Publicado: (2019)

Clostridioides difficile TcdB Toxin Glucosylates Rho GTPase by an S(N)i Mechanism and Ion Pair Transition State
por: Paparella, Ashleigh S., et al.
Publicado: (2022)

Intestinal bile acids provide a surmountable barrier against C. difficile TcdB-induced disease pathogenesis
por: Icho, Simoun, et al.
Publicado: (2023)

Nectin-3 and shed forms of CSPG4 can serve as epithelial cell receptors for Clostridioides difficile TcdB
por: Childress, Kevin O., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k91mj5vdb1gfu9394futijngc5